Ovarian hyperthecosis coexisting with an incidental adrenal lesion: challenges in the diagnostic approach

Giuseppe Giuffrida, Salvatore Giovinazzo, Rosaria Certo, Francesco Trimarchi, Salvatore Cannavò, Rosaria M Ruggeri

Abstract


Ovarian hyperthecosis is the most common cause of hyperandrogenism in women during postmenopausal age. However, its diagnosis is frequently challenging, since several causes must be ruled out, involving both adrenal glands and ovaries. Herein we describe the case of a 62 years old woman addressed to our Unit after the casual detection of an adrenal mass, compatible with an adenoma. Biochemical evaluation revealed gonadotropins in menopausal range, high testosterone and androstenedione, while the patient had been complaining of androgenetic alopecia and hirsutism for some years. Ultrasound imaging revealed only a small increase in ovarian volume, in relationship to the patient’s age. A GnRHa test was performed, demonstrating gonadotropins suppression and testosterone normalization, thus confirming the suspect of ovarian hyperthecosis. The administration of these agonists, together with the slow progression of symptoms over years, play a fundamental role into excluding an androgen-secreting neoplasia, also limiting the use of ovarian veins catheterization as second line test. Besides, they represent a valid therapeutical option, especially when surgery is contraindicated (or cannot be performed).

Keywords


Hyperandrogenism; Hirsutism; Postmenopausal Age

Full Text:

PDF

References


Alpanes, M., Gonzalez-Casbas, J.M., Sanchez, J., Pian, H., Escobar-Morreale, H.F. (2012). Management of post- menopausal virilisation. J Clin Endocrinol Metab, 97, 2584–2588. doi: 10.1210/jc.2012-1683.

Marcondes, J.A.M., Curi, D.D.G., Matsuzaki, C.N., Barcellos, C.R.G., Rocha, M.P., Hayashida, S.A.Y., Baracat, E.C. (2008). Ovarian Hyperthecosis in the Context of an Adrenal Incidentaloma in a Postmenopausal Woman. Arq Bras Endocrinol Metab, 52(7), 1184-1188.

Pascale, M.M., Pugeat, M., Roberts M., Rousset, H., Déchaud, H., Dutrieux-Berger, N., Tourniaire, J. (1994). Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clin Endocrinol (Oxf), 41(5), 571-576.

Vollaard, E.S., van Beek, A.P., Verburg, F.A., Roos, A., Land, J.A. (2011). Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin. J Clin Endocrinol Metab, 96(5), 1197-1201. doi: 10.1210/jc.2010-1991.

Castell, A.L., Hieronimus, S., Chevallier, A., Sadoul, J.L., Galand-Portier, M.B., Delotte, J., Fénichel, P. (2012). Post-menopausal ovarian hyperthecosis. Gynecol Obstet Fertil. 40(5), 316-319. doi: 10.1016/j.gyobfe.2011.07.049.

Polotsky, A.J., Allshouse, A.A., Crawford, S.L., Harlow, S.D., Khalil, N., Kazlauskaite, R., Santoro, N., Legro, R.S. (2014). Hyperandrogenic Oligomenorrhea and Metabolic Risks Across Menopausal Transition. J Clin Endocrinol Metab. 99(6), 2120–2127. doi: 10.1210/jc.2013-4170.

Rousset, P., Gompel, A., Christin-Maitre, S., Pugeat, M., Hugol, D., Ghossain, M.A., Buy, J.N. (2008). Ovarian hyperthecosis on grayscale and color Doppler ultrasound. Ultrasound Obstet Gynecol. 32, 694–699. doi: 10.1002/uog.6131.

Markopoulos, M.C., Kassi, E., Alexandraki, K.I., Mastorakos, G., Kaltsas, G. (2015). Hyperandrogenism after menopause. Eur J Endocrinol 172(2), R79-R91. doi: 10.1530/EJE-14-0468.




DOI: https://doi.org/10.6092/1828-6550/APMB.105.1.2017.A1

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Giuseppe Giuffrida, Francesco Trimarchi

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.